NCT01447472View on ClinicalTrials.gov

-Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2011

Conditions
MetabolismInteraction
Interventions
DRUG

MDMA

One single dose of MDMA ( 1.5 mg/kg; range: 75-100 mg)

Trial Locations (1)

08003

IMIM-Hospital del Mar (Institut de Recerca Hospital del Mar), Barcelona

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Parc de Salut Mar

OTHER

NCT01447472 - -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms | Biotech Hunter | Biotech Hunter